1. Gulba, D.C., Bode, C., Runge, M.S., and Huber, K., Fibrinolysis Proteolysis, 1998, vol. 12, suppl. 2, pp. 39–59.
2. Collen, D. and Lijnen, H.R., Fibrinolysis Proteolysis, 2000, vol. 14, pp. 66–72.
3. Balami, J.S., Chen, R., Sutherland, B.A., and Buchan, A.M., CNS Neurol. Disord. Drug Target, 2013, vol. 12, pp. 145–154.
4. Sinnaeve, P. and van de Werf, F., Thromb. Res., 2001, vol. 103, suppl. 1, pp. S71–S79.
5. The GUSTO Angiographic Investigators, The effects of tissue plasminogen activator, streptokinase, or both on coronary–artery patency, ventricular function, and survival after acute myocardial infarction, Engl. J. Med., 1993, vol. 329, pp. 1615–1622.